Saturday, September 23, 2023
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Biology

UTSA receives $200,000 grant for cancer drug research

October 2, 2017
in Biology
0
Share on FacebookShare on Twitter

Doug Frantz, the Max and Minnie Tomerlin Voelcker Distinguished Professor in Chemistry at The University of Texas at San Antonio (UTSA), has received a $200,000 grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to support his research with April Risinger, assistant professor of pharmacology at UT Health San Antonio, to create new cancer drugs from complex natural products that have proven to be enormously effective in fighting the most aggressive types of cancer.

"The cancer research underway by Dr. Frantz and Dr. Risinger is a wonderful example of how UTSA and UT Health are collaborating to build a knowledge economy in San Antonio," said George Perry, Semmes Foundation Distinguished University Chair in Neurobiology and dean of the UTSA College of Sciences. "This is what being an urban-serving university is all about. We have incredible researchers right here in San Antonio tackling one of the world's greatest health challenges."

Risinger, whose laboratory is focused on the discovery and preclinical development of novel natural products that have anticancer potential, approached Frantz to share her research and the idea that cancer drugs could be developed from a class of natural products called the taccalonolides. She has found that the natural products in this group have a remarkable ability to kill cancer cells, including some of the most aggressive such as drug-resistant triple-negative breast cancer cells.

"The natural products produced by these plants are too structurally complex to recreate and manufacture as drugs as is," Frantz said. "It would be a herculean effort to attempt it. We knew we needed a more innovative, simple solution."

Frantz and Risinger will use the CPRIT funding to discover which aspect of the taccalonolides make them so effective against cancer. Essentially, he's searching for the active portion of the compound so that small part can be recreated and turned into a drug, rather than utilizing the entire natural product itself, which cannot be mass-produced at this stage.

"These plants developed molecules for some other purpose. They don't care about breast cancer," Frantz said. "For us, it's another new opportunity to tackle cancer, especially advanced-stage cancers."

Frantz noted that fighting cancer has become increasingly difficult in recent years, because the disease is evolving to a point that current cancer treatments are no longer as effective as they once were.

"We have to continue to evolve our drugs to overcome that resistance," he said.

###

Media Contact

Joanna Carver
joanna.carver@utsa.edu
361-277-1591
@utsa

http://www.utsa.edu

https://www.utsa.edu/today/2017/10/story/CPRITgrant.html

Share25Tweet16Share4ShareSendShare
  • Null results research now published by major behavioral medicine journal

    1036 shares
    Share 414 Tweet 259
  • New findings on hair loss in men

    67 shares
    Share 27 Tweet 17
  • Fruit flies offer clues to how brains make reward-based decisions

    65 shares
    Share 26 Tweet 16
  • The potential of solar cars in the world

    64 shares
    Share 26 Tweet 16
  • Wildlife mitigating measures no help for Ottawa’s freshwater turtles

    64 shares
    Share 26 Tweet 16
  • ISSCR Kicks off São Paulo International Symposium today in Ribeirão Preto, Brazil

    64 shares
    Share 26 Tweet 16
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Null results research now published by major behavioral medicine journal

Corning® launches Videodrop, revolutionizing real-time nanoparticle detection and analysis

Grant awarded to University of Louisville law professor will fund climate adaptation project

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 208 other subscribers

© 2023 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2023 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In